CD22 and B-cell chronic lymphocytic leukemia: In B-cell chronic lymphocytic leukemia (B-CLL), bryostatin has been shown in vitro to promote differentiation toward a hairy cell leukemia (HCL)-like phenotype, marked by increased expression of CD11c, CD22, and tartrate-resistant acid phosphatase activity [80].